Clinical trial
Can Advair and Flovent Reduce Systemic Inflammation Related to Chronic…
NCT00120978 · University of British Columbia, Other · Unknown status
Key facts
| NCT number | NCT00120978 |
|---|---|
| Title | Can Advair and Flovent Reduce Systemic Inflammation Related to Chronic Obstructive Pulmonary Disease (COPD)? A Multi-Center Randomized Controlled Trial |
| Official title | Advair - CRP Study |
| Lead sponsor | University of British Columbia, Other |
| Collaborators | GlaxoSmithKline Industry |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Chronic Obstructive Pulmonary Disease |
| Intervention type | Drug |
| Interventions | Advair, Flovent |
| Enrollment | 250 |
| Start date | Dec 1, 2004 |
| Completion | Aug 1, 2006 |
| First posted | Jul 19, 2005 |
| Last update posted | May 9, 2006 |
| Countries | Canada |
At a glance
- 10–99 Study sites
- No Results posted
- 10–99 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: